Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2019
April 26, 2018
Share
Eiken Chemical Co., Ltd. reported consolidated and non-consolidated earnings results for the year ended March 31, 2018. For the year, the group reported operating income of ¥3,478 million and net income attributable to shareholders of parent company of ¥2,608 million or ¥70.34 per diluted share on net sales of ¥34,991 million against operating income of ¥3,976 million and net income attributable to shareholders of parent company of ¥2,918 million or ¥78.80 per diluted share on net sales of ¥33,274 million for the same period of last year. Ordinary income was ¥3,549 million against ¥4,112 million a year ago. ROE was 8.3% against 10.0% a year ago. Profit before income taxes was ¥3,474 million against ¥3,845 million for the same period of last year. Net cash provided by operating activities was ¥4,091 million against ¥4,701 million for the same period of last year. Purchase of property, plant and equipment was ¥3,128 million against ¥1,898 million for the same period of last year.
For the year, on non-consolidated basis, the company reported operating income of ¥3,567 million and net income of ¥2,675 million or ¥72.14 per diluted share on net sales of ¥34,981 million against operating income of ¥4,069 million and net income of ¥2,986 million or ¥80.62 per diluted share on net sales of ¥33,253 million for the same period of last year. Ordinary income was ¥3,615 million against ¥4,179 million a year ago.
For the first half of fiscal year ending March 31, 2019, on consolidated basis, the company expects operating income of ¥2,380 million, ordinary income of ¥2,390 million and net income attributable to shareholders of parent company of ¥1,720 million or ¥46.94 per share on net sales of ¥18,480 million.
Fiscal year ending March 31, 2019, on consolidated basis, the company expects operating income of ¥4,200 million, ordinary income of ¥4,230 million and net income attributable to shareholders of parent company of ¥3,040 million or ¥82.97 per share on net sales of ¥36,760 million.
EIKEN CHEMICAL CO., LTD. is a Japan-based company principally engaged in the manufacture and sale of test drugs. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2019